EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

A Systematic Review and Meta-Analysis of the Diagnostic Value of Galectin-3 in Acute Coronary Syndrome

Michal Pruc iD, Zuzanna Gaca, Damian Swieczkowski iD, Jacek Kubica iD, Sagar Galwankar iD, Anna Salak iD, Lukasz Szarpak

Journal of Clinical Medicine · 01.08.2024 · 13 (15) · 4504

DOI: 10.3390/jcm13154504 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.08.2024. Verfasst von Michal Pruc und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research and Development, LUX MED Group, 02-678 Warsaw, Poland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: We investigated the potential diagnostic role of galectin-3 (Gal-3) in patients presenting with suspected acute coronary syndromes (ACS).

Methods

We searched PubMed Central, Scopus, EMBASE, and the Cochrane Library from inception until 20 June 2024. We measured effect sizes using odds ratios (OR) with 95% CIs for dichotomous data and mean differences (MD) with CIs for continuous data. Random synthesis analysis was performed if I2 was less than 50% or Q test p values were less than 0.05. Otherwise, a fixed pooled meta-analysis was performed.

Results

The meta-analysis includes 15 eligible studies. Gal-3 levels were substantially higher in the ACS group (12.84 ± 8.48 ng/mL) compared to the control group (7.23 ± 6.05 ng/mL; MD = 3.89; 95% CI: 2.83 to 4.95; p < 0.001). Gal-3 levels in acute myocardial infarction (AMI) and control groups differed (10.09 ± 8.16 vs. 4.64 ± 3.07 ng/mL, MD = 4.30; 95% CI: 0.41 to 8.18; p < 0.001). Statistical analysis revealed significant differences in Gal-3 levels between ST-elevated myocardial infarction (STEMI) and control groups (10.62 ± 7.34 vs. 5.54 ± 2.96 ng/mL; MD = 5.54; 95% CI: 3.12 to 7.97; p < 0.001). No significant differences were found between the non-ST-elevated myocardial infarction (NSTEMI) vs. control groups or patients with STEMI vs. patients with NSTEMI.

Conclusions

Gal-3 may be beneficial for detecting acute coronary syndromes but not NSTEMI or differentiating between ACS types. This meta-analysis is promising, but further research is needed to prove Gal-3’s potential diagnostic value, exact cut-offs, and advantages over cardiospecific troponins. Gal-3 may be a useful diagnostic biomarker; however, more clinical trials are needed to prove its utility.

Schlagwörter

Stichwörter der Autor:innen

acute coronary syndromebiomarkerdiagnosisgalectin-3inflammation

Autor:innen und Institutionen

  • Department of Clinical Research and Development, LUX MED Group, 02-678 Warsaw, Poland.
  • Department of Public Health, International European University, 03187 Kyiv, Ukraine.
  • Department of Toxicology, Faculty of Pharmacy, Medical University of Gdansk, 80-416 Gdansk, Poland.
  • Department of Cardiology and Internal Medicine, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, 85-094 Bydgoszcz, Poland.
  • Department of Emergency, Florida State University College of Medicine, Emergency Medicine Residency Program, Sarasota Memorial Hospital, Sarasota, FL 32306, USA.
  • Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, 00-136 Warsaw, Poland.

ORCID-Profile: Michal Pruc, Damian Swieczkowski, Jacek Kubica, Sagar Galwankar, Anna Salak

Zitieren

APA

Pruc, M., Gaca, Z., Swieczkowski, D., Kubica, J., Galwankar, S., Salak, A., & Szarpak, L. (2024). A Systematic Review and Meta-Analysis of the Diagnostic Value of Galectin-3 in Acute Coronary Syndrome. Journal of Clinical Medicine, 13(15), 4504. https://doi.org/10.3390/jcm13154504

Vancouver

Pruc M, Gaca Z, Swieczkowski D, Kubica J, Galwankar S, Salak A, et al. A Systematic Review and Meta-Analysis of the Diagnostic Value of Galectin-3 in Acute Coronary Syndrome. Journal of Clinical Medicine. 2024;13(15):4504. doi:10.3390/jcm13154504

BibTeX
@article{Pruc2024,
  author = {Pruc, Michal and Gaca, Zuzanna and Swieczkowski, Damian and Kubica, Jacek and Galwankar, Sagar and Salak, Anna and Szarpak, Lukasz},
  title = {A Systematic Review and Meta-Analysis of the Diagnostic Value of Galectin-3 in Acute Coronary Syndrome},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {15},
  pages = {4504},
  doi = {10.3390/jcm13154504}
}
Kostenlos starten →